开放存取
##reader.subscriptionAccessGranted##
订阅或者付费存取
编号 s3 (2017)
- 年: 2017
- 文章: 5
- URL: https://journals.eco-vector.com/1728-2985/issue/view/7236
Articles
Lower urinary tract symptoms and benign prostatic hyperplasia
Urologiia. 2017;(s3):4-18
4-18
Female urinary incontinence
Urologiia. 2017;(s3):19-35
19-35
Lower urinary tract symptoms secondary to benign prostatic hyperplasia in 2017: update from the 32nd annual congress of European association of urology
摘要
This review article summarizes new data on mono- and combination therapy for male urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). A special attention is paid to the reports made at the 32nd Annual EAU Congress and published in the congress proceedings. The article outlines new data on the epidemiology of LUTS secondary to BPH, recent changes in the pathogenesis of LUTS, provides a critical analysis of the latest publications on а-blockers, 5а-reductase inhibitors, antimuscarinics and phosphodiesterase type 5 inhibitors in pharmacological management of LUTS. The authors analyze recent data on the effectiveness of surgical methods for treating BPH
Urologiia. 2017;(s3):36-44
36-44
Conservative management of benign prostatic hyperplasia: are urologists satisfied?
摘要
The author presents his point of view on the conservative management of benign prostatic hyperplasia and the role of combination therapy (co-administration of α-blockers and 5α-reductase inhibitors) in the treatment of voiding symptoms. The latest evidence for combination therapy of prostatic hyperplasia published in 2017 is also presented.
Urologiia. 2017;(s3):45-47
45-47
PRAVILA PUBLIKATsII V ZhURNALE "UROLOGIYa"
Urologiia. 2017;(s3):48-48
48-48